FDAsafety guidance66% confidence
Global Generic Drug Affairs
Source: FDA
Why This Matters
Why this matters: provides agency context on safety guidance that may shape timing or evidence expectations for Accord Biopharma; the same agency is already in play for this signal, so precedent weight is higher.
Regulatory Analysis
FDA’s Office of Generic Drugs (OGD) ensures, through a scientific and regulatory process, that Americans have access to safe, effective, and high-quality generic drugs.
Supporting Context
- Therapeutic area
- Hematology · Neutropenia
- Sub-indication
- General
Related signal: FDA Accepts BLA761147 for PEGFILGRASTIM-PCCG by Accord Biopharma